We are live on ! Find out more
PIM

Partner Investment Management Portfolio holdings

AUM $13.9M
1-Year Est. Return 55.92%
This Fund
S&P 500
This Quarter Est. Return
+5.8%
1 Year Est. Return
+55.92%
3 Year Est. Return
+168.07%
5 Year Est. Return
+301.91%
10 Year Est. Return
–
AUM
$61.1M
AUM Growth
-$266K
Cap. Flow
-$5.25M
Cap. Flow %
-8.59%
Top 10 Hldgs %
31.78%
Holding
108
New
30
Increased
19
Reduced
22
Closed
32

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$1.88M
2
AET
Aetna Inc
AET
+$1.8M
3
BAX icon
Baxter International
BAX
+$1.22M
4
MCK icon
McKesson
MCK
+$1.04M
5
UNH icon
UnitedHealth
UNH
+$1.03M

Top Sells

Rank Stock Value
1
HCA icon
HCA Healthcare
HCA
+$2.28M
2
AGN
Allergan plc
AGN
+$1.83M
3
BMY icon
Bristol-Myers Squibb
BMY
+$1.81M
4
AAPL icon
Apple
AAPL
+$1.65M
5
GILD icon
Gilead Sciences
GILD
+$1.6M

Sector Composition

Rank Sector Weight
1 Healthcare 40.86%
2 Technology 8.54%
3 Communication Services 4.28%
4 Financials 4.21%
5 Energy 3.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VMC icon
51
Vulcan Materials
VMC
$36.9B
$357K 0.58%
2,964
-5,566
-65% -$630K
ZLTQ
52
DELISTED
ZELTIQ Aesthetics, Inc.
ZLTQ
$347K 0.57%
12,713
-7,261
-36% -$204K
GBT
53
DELISTED
Global Blood Therapeutics, Inc.
GBT
$338K 0.55%
20,383
+3,535
+21% +$71.3K
MOH icon
54
Molina Healthcare
MOH
$9.99B
$322K 0.53%
+6,445
New +$344K
RICE
55
DELISTED
Rice Energy Inc.
RICE
$322K 0.53%
+14,613
New +$273K
GWPH
56
PUT
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$302K 0.49%
+3,300
New +$278K
V icon
57
Visa
V
$690B
$295K 0.48%
+3,982
New +$312K
VRTX icon
58
Vertex Pharmaceuticals
VRTX
$121B
$295K 0.48%
+3,425
New +$296K
VYGR icon
59
Voyager Therapeutics
VYGR
$189M
$288K 0.47%
26,187
+11,852
+83% +$145K
VIPS icon
60
Vipshop
VIPS
$7.49B
$275K 0.45%
+24,662
New +$302K
KITE
61
DELISTED
Kite Pharma, Inc.
KITE
$253K 0.41%
5,060
-482
-9% -$23.7K
LIVN icon
62
LivaNova
LIVN
$4.69B
$251K 0.41%
+4,993
New +$252K
SLCA
63
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
$223K 0.36%
+6,456
New +$179K
HDP
64
DELISTED
Hortonworks, Inc.
HDP
$212K 0.35%
19,799
-3,211
-14% -$36.2K
AAPL icon
65
Apple
AAPL
$4.52T
$211K 0.35%
8,828
-66,232
-88% -$1.65M
MYOK
66
DELISTED
MyoKardia, Inc. Common Stock
MYOK
$201K 0.33%
16,187
+687
+4% +$8.59K
SPNC
67
DELISTED
Spectranetics Corp
SPNC
$108K 0.18%
5,780
-380
-6% -$6.69K
DMTX
68
DELISTED
Dimension Therapeutics, Inc
DMTX
$89K 0.15%
14,761
-1,539
-9% -$11.7K
KURA icon
69
Kura Oncology
KURA
$841M
$62K 0.1%
23,023
+3,001
+15% +$9.33K
INVA icon
70
Innoviva
INVA
$1.54B
$28K 0.05%
2,703
-31,270
-92% -$370K
INSY
71
PUT
DELISTED
Insys Therapeutics, Inc.
INSY
$14K 0.02%
+1,100
New +$16K
ABBV icon
72
CALL
AbbVie
ABBV
$431B
– –
-18,200
Closed -$1.04M
ACHC icon
73
Acadia Healthcare
ACHC
$2.95B
– –
-2,765
Closed -$152K
AMT icon
74
American Tower
AMT
$81.7B
– –
-2,136
Closed -$219K
BLK icon
75
Blackrock
BLK
$175B
– –
-3,272
Closed -$1.11M
1 2
3
4 5

Similar funds

SWM
Sequoia Wealth Management Hoffman Estates, Illinois $12.9M AUM 25.75% 1-Year Est. Return
ACM
ADI Capital Management New York $17.5M AUM 49.32% 1-Year Est. Return
ECAU
Everett Capital Advisors (UK) London, United Kingdom $18.6M AUM 22.81% 1-Year Est. Return
SL
Signition LP New York $20M AUM 28.26% 1-Year Est. Return
DII
Domini Impact Investments New York $7.59M AUM 47.68% 1-Year Est. Return
FIM
FourPoints Investment Managers Paris, France $21.1M AUM 11.11% 1-Year Est. Return
EM
Emancipation Management New York $22.4M AUM 18.33% 1-Year Est. Return
BHC
Balch Hill Capital San Francisco, California $22.8M AUM

Partner Investment Management's Q2 2016 Portfolio in Review

As of Q2 2016, Partner Investment Management held 108 positions worth $61.1M, down 0.43% from $61.4M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Partner Investment Management withdrew a net $5.25M in Q2 2016, closing 32 positions and reducing 22 holdings. Its most notable exit was Allergan plc, an estimated $1.83M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 41% of assets, down from 48% a quarter earlier, followed by Technology and Communication Services.

Against the trend, Partner Investment Management opened a new position in Biogen worth $1.73M.

  • Partner Investment Management's largest Q2 2016 buy was Biogen: 7,139 shares worth $1.73M.
  • Partner Investment Management added most to Aetna Inc in Q2 2016, an estimated $1.8M increase.
  • Partner Investment Management's biggest Q2 2016 reduction was HCA Healthcare, cutting an estimated $2.28M.
  • Partner Investment Management fully exited Allergan plc in Q2 2016, selling an estimated $1.83M.
  • Partner Investment Management's ten largest holdings make up 32% of its $61.1M portfolio in Q2 2016.
  • Partner Investment Management opened 30 new positions and closed 32 in Q2 2016.
  • Partner Investment Management's portfolio value fell 0.43% quarter-over-quarter to $61.1M.

Based on Partner Investment Management's 13F filing for Q2 2016, filed 15 Aug 2016.